Cellmid Limited that independent chairman, Dr. David King, will leave the Board on 31 December 2020. The temporary extension of Dr. King's tenure assisted in an orderly transition and the new independent chairman, Mr. Bruce Gordon, will take over from 1 January 2021. Mr. Gordon will also chair the Company's Nomination and Remuneration Committee from 1 January 2020, while relinquishing his role as Chair of the Audit Committee to Dr. Martin Cross.